Clinical Trial Update: Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status [Phase 2]

View source ↗

Summary

A Phase II neoadjuvant trial in T1c operable, HER2-positive breast cancer defined by TOP2A status has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: UNICANCER | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED